APA (7th ed.) Citation

Janssen, M., Schäkel, U., Djuika, C. F., Krisam, J., Stermann, J., Kriegsmann, K., . . . Müller-Tidow, C. (2020). A randomized open label phase-II clinical trial with or without infusion of plasma from subjects after convalescence of SARS-CoV-2 infection in high-risk patients with confirmed severe SARS-CoV-2 disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial. Trials, 21, . https://doi.org/10.1186/s13063-020-04735-y

Chicago Style (17th ed.) Citation

Janssen, Maike, et al. "A Randomized Open Label Phase-II Clinical Trial with or Without Infusion of Plasma from Subjects After Convalescence of SARS-CoV-2 Infection in High-risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Trials 21 (2020). https://doi.org/10.1186/s13063-020-04735-y.

MLA (9th ed.) Citation

Janssen, Maike, et al. "A Randomized Open Label Phase-II Clinical Trial with or Without Infusion of Plasma from Subjects After Convalescence of SARS-CoV-2 Infection in High-risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A Structured Summary of a Study Protocol for a Randomised Controlled Trial." Trials, vol. 21, 2020, https://doi.org/10.1186/s13063-020-04735-y.